Simcere Pharmaceutical Group Ltd
HKEX:2096
Simcere Pharmaceutical Group Ltd
Cash from Investing Activities
Simcere Pharmaceutical Group Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Simcere Pharmaceutical Group Ltd
HKEX:2096
|
Cash from Investing Activities
¥68.3m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Investing Activities
-¥5.9B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Investing Activities
¥73.3m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Investing Activities
¥518.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Investing Activities
-¥93m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
See Also
What is Simcere Pharmaceutical Group Ltd's Cash from Investing Activities?
Cash from Investing Activities
68.3m
CNY
Based on the financial report for Dec 31, 2023, Simcere Pharmaceutical Group Ltd's Cash from Investing Activities amounts to 68.3m CNY.
What is Simcere Pharmaceutical Group Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-49%
Over the last year, the Cash from Investing Activities growth was 0%. The average annual Cash from Investing Activities growth rates for Simcere Pharmaceutical Group Ltd have been -49% over the past three years .